Markets:

Overview

News

Currencies

International

Treasuries

Sage Therapeutics, Inc. - Common Stock (NQ:SAGE)

8.680 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sage Therapeutics, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

PayPal Unveils USD-Backed Stablecoin, Trucking Firm Yellow Corp Files For Bankruptcy, FDA Approves First Oral Treatment For Postpartum Depression: Today's Top Stories ↗

August 07, 2023

Benzinga

Via Benzinga

Why Sage Therapeutics Shares Are Sinking Monday ↗

August 07, 2023

Sage Therapeutics Inc (NASDAQ: SAGE) shares are trading lower Monday after the company announced the FDA issued a Complete Response Letter (CRL) for one of the company's

Via Benzinga

SOVO Stock Alert: Campbell Soup Is Buying Sovos Brands for $2.7 Billion ↗

August 07, 2023

Sovos Brands (SOVO) stock is rising higher on Monday following news that Campbell Soup (CPB) is acquiring the Italian sauces company.

Via InvestorPlace

Dow Jumps 250 Points; Tyson Foods Posts Downbeat Results ↗

August 07, 2023

U.S. stocks were higher this morning, with the Dow Jones gaining more than 250 points on Monday. Following the market opening Monday, the Dow traded up 0.77% to 35,334.81 while the NASDAQ rose 0.42% to...

Via Benzinga

What 10 Analyst Ratings Have To Say About Sage Therapeutics ↗

July 27, 2023

Via Benzinga

Expert Ratings for Sage Therapeutics ↗

May 09, 2023

Via Benzinga

Sage Therapeutics's Earnings Outlook ↗

May 01, 2023

Via Benzinga

Why Is Sage Therapeutics (SAGE) Stock Down 48% Today? ↗

August 07, 2023

Sage Therapeutics (SAGE) stock isn't doing the best on Monday after the FDA weighed in on the company's depression drug zuranolone.

Via InvestorPlace

Why Sage Lost Half Its Value After The FDA Approved Its Depression Drug ↗

August 07, 2023

The company gained approval for the first oral treatment for postpartum depression.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 07, 2023

Via Benzinga

FDA Approves Sage Therapeutics/Biogen's Zuranolone For One Type Of Depression, Rejects For Another ↗

August 07, 2023

The FDA approved Sage Therapeutics Inc (NASDAQ: SAGE) and Biogen Inc's (NASDAQ: BIIB) Zurzuvae (zuranolone) 50 mg for adults with

Via Benzinga

Wayfair To Rally Over 32%? Here Are 10 Other Analyst Forecasts For Monday ↗

August 07, 2023

Needham raised the price target for MACOM Technology Solutions Holdings, Inc. (NASDAQ: MTSI) from $65 to $84. Needham analyst Quinn Bolton maintained a Buy rating. MACOM Technology shares rose 0.1% to...

Via Benzinga

Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress

August 07, 2023

From Sage Therapeutics, Inc.

Via Business Wire

Sage Therapeutics to Host Business Update Webcast and Announce Second Quarter Financial Results on Monday, August 7, 2023

August 04, 2023

From Sage Therapeutics, Inc.

Via Business Wire

FDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral Treatment Approved for Women with Postpartum Depression, and Issues a Complete Response Letter for Major Depressive Disorder

August 04, 2023

From Sage Therapeutics, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

July 31, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023 ↗

July 27, 2023

Via Benzinga

Why Sage Therapeutics Stock Is Tumbling Today ↗

July 26, 2023

A partner's perceived lack of enthusiasm for an upcoming regulatory decision is spooking investors today.

Via The Motley Fool

Why Universal Health Services Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 26, 2023

Gainers Silicon Motion Technology Corporation (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting China approval of the company's Maxlinear merger.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 26, 2023

Via Benzinga

Sage Therapeutics to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

June 05, 2023

From Sage Therapeutics, Inc.

Via Business Wire

Sage Therapeutics to Present at Upcoming May Investor Conferences

May 03, 2023

From Sage Therapeutics, Inc.

Via Business Wire

Sage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress

May 02, 2023

From Sage Therapeutics, Inc.

Via Business Wire

Sage Therapeutics to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023

April 18, 2023

From Sage Therapeutics, Inc.

Via Business Wire

Sage Therapeutics to Present at the Stifel 2023 CNS Days

March 22, 2023

From Sage Therapeutics, Inc.

Via Business Wire

Sage Therapeutics Appoints Jessica Federer to Board of Directors

March 16, 2023

From Sage Therapeutics, Inc.

Via Business Wire

Analyst Creates Bullish Pitch For Sage Therapeutics Around Greater Enthusiasm For Its Depression Drug, Zuranolone ↗

March 13, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023 ↗

March 13, 2023

Via Benzinga

Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 13, 2023

Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.

Via Benzinga

Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗

March 13, 2023

U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.